AVLN · NASDAQ · Biotechnology

Avalyn Pharma (AVLN)

Develops inhaled pirfenidone and nintedanib candidates for pulmonary fibrosis.

$29.67
After hours−0.12 (−0.40%)
At close$29.79(−8.20%)